Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

IPSEN's Stock Rebounds by 2.58% at the Close of November 10

IPSEN ends the day on a strong upward trend, breaking through key technical thresholds at close. Priced at 127 euros, the pharmaceutical giant's stock shows a rebound of over 2.50% during the session, in a generally favorable market environment. This increase is part of a positive trend observed over several sessions.


IPSEN's Stock Rebounds by 2.58% at the Close of November 10

Stock Performance Details

The stock reached 127.00 euros at the close of Monday, November 10, marking a gain of 2.58% compared to Friday's closing price of 123.80 euros. The CAC 40 advanced by 1.32% over the same period, providing a generally favorable context for the pharmaceutical sector. On a weekly basis, IPSEN records a performance of 4.27%, confirming the strength of the upward movement beyond just one day. Over the medium term, the stock has shown a progression of 19.47% over three months and 15.14% over twelve months, thus outperforming the flagship index's performance, which stands at 9.77%. However, the liquidity of transactions remains limited, with a capital turnover rate established at only 0.15%, reflecting a relative caution of investors regarding volumes. This observation suggests a nuanced consideration of the intensity of observed movements, which occur in a restricted trading framework where transactions take place at low density.

Technical Analysis and Future Outlook

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

From a technical standpoint, IPSEN has broken the resistance set at 124.90 euros, potentially paving the way for exploration of higher levels. The stock is now trading above its structural moving averages, with the MM50 positioned at 117.50 euros and the MM200 at 109.28 euros, confirming a bullish architecture in the short and medium term. The Relative Strength Index (RSI) shows a reading of 77, indicating an overbought market that may impact the short-term dynamics. The MACD is advancing with its main line at 2.11 euros against its signal line at 1.69 euros, while the histogram remains positive at 0.42, indicating the persistence of an upward momentum. The stochastic signal confirms this trend by generating a buy signal. The stock is trading slightly above the upper Bollinger Band set at 126.97 euros, demonstrating a bullish extension beyond the statistical envelope. The On-Balance Volume (OBV) index shows a negative value of -181,974, reflecting a relatively limited commitment in the observed rise, thus tempering the robustness of the accumulated gains.



Sector Santé · Pharmacie Industrie Pharmaceutique


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 3 675,9 millions d'euros
  • Revenue growth: 8,1 %
  • EBITDA: 1 383,3 millions d'euros
  • EBITDA margin: 37,6 %
  • Net income: 444,5 millions d'euros
  • Free cash flow: 1 000,6 millions d'euros
  • Dividend per share: 1,40 €
  • Payout ratio: 26,1 %
Guidance from the release
  • "En 2025, Ipsen a enregistré une croissance solide de son chiffre d'affaires et de son résultat opérationnel."
  • Ipsen a publié ses résultats 2025 et T4 2025: chiffre d'affaires de 3 675,9 millions d'euros, croissance YoY de 8,1%; Résultat opérationnel des activités de 1 294,1 millions d'euros, marge de 35,2%; Résultat net consolidé IFRS de 444,5 millions d'euros; Bénéfice dilué par action IFRS de 5,32 euros; Cash-flow libre de 1 000,6 millions d'euros; Dividende par action de 1,40 euro.
Outlook / guidance
  • Expected revenue: Une croissance des ventes totales supérieure à 13,0 % à taux de change constant en 2026
  • Management commentary: Ipsen prévoit en 2026 une croissance des ventes totales supérieure à 13,0% à taux de change constant et une marge opérationnelle des activités supérieure à 35,0%.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit